FDA issues recalls on at least 16 food and drug items in September. Here's a list
The FDA has removed the following items from store shelves this September, including pet food, baby powder and Lactaid.
US FDA approves GE HealthCare's diagnostic drug for heart disease
The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...
FDA’s proposed packaged food labels won’t fix our obesity epidemic
A clear FDA public education campaign could help shoppers make healthier choices. But it should first pay attention to the ...
RiverBender.com13m
FDA Approves Updated COVID-19 Vaccine for 2024-2025 Season
The fall virus season is upon us, and the U.S. Food & Drug Administration just approved one of the newest tools to protect ...
Medscape3h
FDA Panel Votes for Limits on Gastric, Esophageal Cancer Immunotherapy
After hours of company pushback, FDA's Oncologic Drugs Advisory Committee voted that the benefit of immunotherapy in low or ...
Food57m
Soup-To-Nuts Podcast: Does FDA’s proposed post-market assessment of chemicals in food fit the bill?
Food and beverage industry stakeholders and consumer advocates are lauding FDA’s commitment to enhance its post-market ...
FierceBiotech1h
With post hoc analysis, BridgeBio touts case for acoramidis as FDA decision date draws near
BridgeBio Pharma has been on the road to redemption ever since its treatment for a rare and fatal heart condition, acoramidis ...
Modalis wins FDA rare paediatric designation for CMD CRISPR therapy
Modalis Therapeutics has been awarded a rare paediatric disease designation by the US Food and Drug Administration (FDA) for ...
FDA: Some pet foods from Answers, Darwin’s Natural test positive for bacteria
Pet owners are urged to check for potentially contaminated products that could make them or their furry friends sick after two brands tested positive for bacteria.
Accelerate Diagnostics' Accelerate Arc System Receives FDA 510 (k) Clearance
Monday, Accelerate Diagnostics, Inc. (AXDX) announced that the FDA has granted 510(k) clearance for its Accelerate Arc system and BC ...
FDA Approves the First New Schizophrenia Drug in Decades
Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...
EQS-News: Formycon and Fresenius Kabi receive FDA approval for FYB202/ OtulfiTM (ustekinumab-aauz)
Formycon and Fresenius Kabi receive FDA approval for FYB202/ OtulfiTM (ustekinumab-aauz) Otulfi TM received FDA approval for both subcutaneous and intravenous formulations, to treat the same ...